🚀 Panacea Biotec Extends Rally, Nears All-Time High

remained in strong momentum after Thursday’s bulk deal-driven surge, with the stock hitting the 20% upper circuit and extending gains on the Friday’s session. The stock climbed to ₹577.65, marking a fresh 52-week high and moving within touching distance of its all-time high of ₹581.90 recorded in May 2025. The rally follows a bulk deal in which OHM Investment Corporation acquired 3.14 lakh shares, representing a 0.51% stake, for ₹15.52 crore at ₹493.07 per share. The buying interest has significantly boosted investor sentiment, with the stock gaining more than 30% on a weekly basis, making it one of the standout performers in the small-cap healthcare space. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.